Preconception carrier screening and preimplantation genetic testing in the infertility management
Andrology · 2025-07 · 13 (5) · 1065-1077
DOI: 10.1111/andr.13744 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Andrology, online erschienen am 21.08.2024. Verfasst von Silvia Caroselli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Juno Genetics, Rome, Italy. Hauptthemen laut MEDLINE: Preimplantation Diagnosis, Preconception Care, Infertility, Genetic Carrier Screening. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 122 Literaturangaben.
Abstract (Originalsprache)
Background
Genetic testing serves as a valuable element of reproductive care, applicable at various stages of the reproductive journey: (i) before pregnancy, when a couple's genetic reproductive risk can be evaluated; (ii) before embryo implantation, as part of in vitro fertilization (IVF) treatment, to ascertain several inherited or de novo genetic/chromosomal diseases of the embryo before transfer; (iii) during the prenatal period, to assess the genetic costitution of the fetus. Preconception carrier screening (CS) is a genetic test typically performed on couples planning a pregnancy. The primary purpose of CS is to identify couples at‐risk of conceiving a child affected by a severe genetic disorder with autosomal recessive or X‐linked inheritance. Detection of high reproductive risk through CS allows prospective parents to be informed of their predisposition and improve reproductive decision‐making. These include undergoing IVF with preimplantation genetic testing (PGT) or donor gametes, prenatal diagnosis, adoption, remaining childless, taking no actions. Both the presence of the affected gene (PGT‐M) and chromosomal status (PGT‐A) of the embryo can be comprehensively assessed through modern approaches.
Objectives
We provide a review of CS and PGT applications to equip healthcare providers with up‐to‐date information regarding their opportunities and complexities. Results and Discussion The use of CS and PGT is currently considered the most effective intervention for avoiding both an affected pregnancy whilst using autologous gametes in couples with known increased risk, and chromosomal abnormalities. As our understanding in the genetic component in pathological conditions increases, the number of tested disorders will expand, offering a more thorough assessment of one's genetic inheritance. Nevertheless, implementation and development in this field must be accompanied by scientific and ethical considerations to ensure this approach serves the best long‐term interests of individuals and society, promoting justice and autonomy and preserving parenthood and the healthcare system.
Conclusion
The combination of CS and PGT aligns with principles of personalized medicine by offering reproductive care tailored to the individual's genetic makeup.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Juno Genetics, Rome, Italy.
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
- Unit of Molecular Genetics, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti-Pescara, Italy.
- Department of Psychological Health and Territorial Sciences, School of Medicine and Health Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti-Pescara, Italy.
ORCID-Profile: Antonio Capalbo
Zitieren
APA
Caroselli, S., Poli, M., Gatta, V., Stuppia, L., & Capalbo, A. (2025). Preconception carrier screening and preimplantation genetic testing in the infertility management. Andrology, 13(5), 1065-1077. https://doi.org/10.1111/andr.13744
Vancouver
Caroselli S, Poli M, Gatta V, Stuppia L, Capalbo A. Preconception carrier screening and preimplantation genetic testing in the infertility management. Andrology. 2025;13(5):1065-1077. doi:10.1111/andr.13744
BibTeX
@article{Caroselli2025,
author = {Caroselli, Silvia and Poli, Maurizio and Gatta, Valentina and Stuppia, Liborio and Capalbo, Antonio},
title = {Preconception carrier screening and preimplantation genetic testing in the infertility management},
journal = {Andrology},
year = {2025},
volume = {13},
number = {5},
pages = {1065--1077},
doi = {10.1111/andr.13744}
}
EUVIMED